{"url_path":"/sec/tyra/10-q/2026/item-5","section_key":"item-5","section_title":"Item 5 Other Information","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-13","source_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-220645-index.html","accession_number":"0001193125-26-220645","cik":"0001863127","ticker":"TYRA","issuer_name":"Tyra Biosciences, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1863127/0001193125-26-220645-index.html","primary_entity_key":"0001863127","primary_entity_name":"Tyra Biosciences, Inc."},"word_count":194,"has_tables":true,"body_markdown":"Item 5. Other Information\n\nDirector and Officer Trading Arrangements\n\nRule 10b5-1 Trading Plans\n\nFrom time to time, our officers (as defined in Rule 16a-1(f) of the Exchange Act) and directors may enter into Rule 10b5-1 or non-Rule 10b5-1 trading arrangements (as each such term is defined in Item 408 of Regulation S-K). During the three months ended March 31, 2026, our officers and directors took the following actions with respect to such trading arrangements:\n\n \n\n \n\n \n\n \n\n \n\n \n\nTrading Arrangement\n\n \n\n \n\n \n\n \n\n \n\nName and Title\n\n \n\nAction\n\n \n\nDate\n\n \n\nRule 10b5-1*\n\n \n\nNon-Rule 10b5-1**\n\n \n\nTotal Shares Authorized to be Sold***\n\n \n\n \n\nExpiration Date\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nTodd Harris\nPresident, Chief Executive Officer and Director\n\n \n\nAdoption\n\n \n\n3/6/2026\n\n \n\nX\n\n \n\n \n\n \n\n \n\n100,000\n\n \n\n \n\n12/30/2027\n\nAlan Fuhrman\nChief Financial Officer\n\n \n\nAdoption\n\n \n\n3/20/2026\n\n \n\nX\n\n \n\n \n\n \n\n \n\n100,000\n\n \n\n \n\n12/30/2027\n\nJulia Rueb\nVice President, Finance (principal accounting officer)\n\n \n\nAdoption\n\n \n\n3/6/2026\n\n \n\nX\n\n \n\n \n\n \n\n \n\n56,975\n\n \n\n \n\n10/20/2027\n\n \n\n* Intended to satisfy the affirmative defense of Rule 10b5-1(c)\n\n** Not intended to satisfy the affirmative defense of Rule 10b5-1(c)\n\n*** Represents the maximum number of shares that may be sold pursuant to the 10b5-1 arrangement. The number of shares sold is dependent on the satisfaction of certain conditions as set forth in the written plan and the satisfaction of applicable vesting conditions of equity awards.\n\n24"}